Back to KRYS
Soleus Capital Management, L.P. → KRYS
Soleus Capital Management, L.P. KRYS Position History
Krystal Biotech, Inc. • Healthcare
Quarters held
4
Latest value
$379M
Q3 2026
Peak value
$379M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $232M |
| Q1 2026 | $297.9M |
| Q2 2026 | $349.1M |
| Q3 2026 | $379M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $379M | 1.14M | — | — |
| Q2 2026 | $349.1M | 939.3K | — | — |
| Q1 2026 | $297.9M | 1.15M | — | — |
| Q4 2025 | $232M | 941.1K | — | — |
Other funds holding KRYS
$1.2B
$1.1B
$1.1B
$960.7M
$857.3M
$814.4M
$774.3M